The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 31, No. 1, pp. 53-55.
© 1997 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jurovich, M.
Right arrow Articles by Force, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jurovich, M.
Right arrow Articles by Force, R.


Research Articles

Metformin-associated nonketotic metabolic acidosis

MR Jurovich, JD Wooldridge, and RW Force

OBJECTIVE: To document a case of anion gap, nonketotic metabolic acidosis occurring in a patient with acute renal failure who was receiving metformin. CASE SUMMARY: A 67-year-old white man presented with a 9-day history of weakness, nausea, dizziness, and difficulty moving; he had also not eaten during the previous 2 days. The patient had numerous abnormalities on his serum chemistry panel and arterial blood gases, including a pH of 7.1 and an anion gap of 21 mEq/L No ketones were detected in the urine. The patient was treated with intravenous fluids, sodium bicarbonate, insulin, and hemodialysis. All medications were discontinued. The acidosis resolved shortly after hemodialysis. The hospital course was complicated by the onset of atrial fibrillation occurring on day 2 that did not respond to chemical cardioversion. On day 6 the patient was discharged home with resolving acute renal failure and normal serum pH. CONCLUSIONS: The mortality rate of biguanide-induced lactic acidosis is approximately 50%; thus, early recognition and treatment are essential. Suspicion of lactic acidosis should be high when diabetic patients who are taking a biguanide present with acidosis. The majority of cases of metformin-induced lactic acidosis have occurred in patients with contraindications to the drug (i.e., renal dysfunction). Thus, it is important to maintain strict adherence to these contraindications and monitor patients for deteriorating renal function.


This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
M. Forrester
Adult metformin ingestions reported to Texas poison control centers, 2000-2006
Human and Experimental Toxicology, July 1, 2008; 27(7): 575 - 583.
[Abstract] [PDF]


Home page
Am J Health Syst PharmHome page
H. A. Spiller and T. S. Sawyer
Toxicology of oral antidiabetic medications
Am. J. Health Syst. Pharm., May 15, 2006; 63(10): 929 - 938.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
H. A Spiller and D. A Quadrani
Toxic Effects from Metformin Exposure
Ann. Pharmacother., May 1, 2004; 38(5): 776 - 780.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1997 by Harvey Whitney Books Company.